Inflammatory Signatures Associated with Obesity in Patients with Stage II Breast Cancer Receiving Doxorubicin- Cyclophosphamide Therapy
The results point to the possibility of obesity-related inflammation in the formation of the biological context of chemotherapy and justify the use of inflammatory profiling in individual breast cancer management.